Bozina Nada, Granić Paula, Lalić Zdenka, Tramisak Inja, Lovrić Mila, Stavljenić-Rukavina Ana
University Institute of Laboratory Diagnosis, Zagreb University Hospital Center and School of Medicine, Zagreb, Croatia.
Croat Med J. 2003 Aug;44(4):425-8.
To determine the prevalence of most common mutations of cytochrome P450 (CYP), ie, allelic variants of CYP2C9, CYP2C19, and CYP2D6, and to predict genotype frequency in the Croatian population.
CYP genotype was determined in 200 non-related Croatian citizens. DNA isolated from blood samples was used for the analysis of the most common allelic variants of CYP2C9, CYP2C19, and CYP2D6 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
For 200 subjects genotyped for CYP2C9, the allele frequencies of CYP2C91 (wt), CYP2C92, and CYP2C93 were 0.74, 0.165, and 0.095, respectively. Among them, 3.5% of subjects were predicted to be poor metabolizers. For CYP2C19, the most frequent alleles were CYP2C191 and CYP2C192, with frequencies of 0.85 and 0.15, respectively; 3% of subjects were predicted to be poor metabolizers. For CYP2D6, the most frequent alleles were CYP2D61 (frequency 0.765), CYP2D62* (0.04), CYP2D63 (0.0275), CYP2D64 (0.14), CYP2D65 ( 0.01), and CYP2D66 (0.015). Out of these, 3% were predicted to be poor metabolizers, and 4% were predicted to be ultra-rapid metabolizers.
The prevalence of allelic variants and predicted genotypes in the Croatian population is in accordance with the other European populations, and it can be interpolated between the values for mid-European and Mediterranean populations.
确定细胞色素P450(CYP)最常见突变的流行情况,即CYP2C9、CYP2C19和CYP2D6的等位基因变体,并预测克罗地亚人群中的基因型频率。
对200名无亲属关系的克罗地亚公民进行CYP基因型检测。从血液样本中分离的DNA用于通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法分析CYP2C9、CYP2C19和CYP2D6最常见的等位基因变体。
对200名进行CYP2C9基因分型的受试者,CYP2C91(野生型)、CYP2C92和CYP2C93的等位基因频率分别为0.74、0.165和0.095。其中,3.5%的受试者被预测为慢代谢者。对于CYP2C19,最常见的等位基因是CYP2C191和CYP2C192,频率分别为0.85和0.15;3%的受试者被预测为慢代谢者。对于CYP2D6,最常见的等位基因是CYP2D61(频率0.765)、CYP2D62*(0.04)、CYP2D63(0.0275)、CYP2D64(0.14)、CYP2D65(0.01)和CYP2D66(0.015)。其中,3%被预测为慢代谢者,4%被预测为超快代谢者。
克罗地亚人群中等位基因变体和预测基因型的流行情况与其他欧洲人群一致,且可在中欧和地中海人群的值之间进行插值。